Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Halima El Omri"'
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
IntroductionVenetoclax is a BCL-2 inhibitor with proven efficacy in patients with multiple myeloma (MM) and translocation t(11;14). However, its role in plasma cell leukemia (PCL) remains unclear. Herein, we aimed to report a case of relapsed MM with
Externí odkaz:
https://doaj.org/article/470c774a7af44ec1ad222975166f1030
Autor:
Murtadha K. Al-Khabori, Ahmad Alhuraiji, Arif R. Alam, Faraz A. Khan, Halima El Omri, Hani Y. Osman, Hasan M. AaL Yaseen, Mahdiya Pir Al Bulushi, Ramesh K. Pandita, Mahmoud M. Marashi
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEAML is a heterogeneous hematologic malignancy. Region-specific recommendations for AML management can enhance patient outcomes. This article aimed to develop recommendations for the Gulf Cooperation Council (GCC) countries.METHODSTen AML panel
Externí odkaz:
https://doaj.org/article/d42eb2fa89c7415aa1320ed40b7819d9
Autor:
Halima El Omri, Regina Padmanabhan, Ruba Y. Taha, Nancy Kassem, Hesham Elsabah, Anil Yousaf Ellahie, Antonio J.J. Santimano, Muna A. Al-Maslamani, Ali S. Omrani, Adel Elomri, Abdelfatteh El Omri
Publikováno v:
Journal of Infection and Public Health, Vol 17, Iss 1, Pp 152-162 (2024)
Background: The use of ill-suited antibiotics is a significant risk factor behind the increase in the mortality, morbidity, and economic burden for patients who are under treatment for hematological malignancy (HM) and bloodstream infections (BSI). S
Externí odkaz:
https://doaj.org/article/de080622001e4224b0cc8e309bdba180
Autor:
Hesham Elsabah, Halima El Omri, Elmukhtar Habas, Ruba Y. Taha, Sarah A. ElKourashy, Feryal Ibrahim, Abdulqadir J. Nashwan, Nancy Kassem, Laxmi Ojha, Rajvir Singh, Rola Ghasoub, Abdelfatteh El Omri
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundMultiple myeloma (MM) is one of the most common hematological malignancies globally, and it is projected to increase in the coming years. It occurs more frequently in males and affects older individuals. Presenting symptoms can range from b
Externí odkaz:
https://doaj.org/article/d3612795947545d28ef6dbfdd55556e2
Publikováno v:
Hematology, Vol 28, Iss 1 (2023)
ABSTRACTBackground: Cold agglutinin disease (CAD) is immune-mediated hemolytic anemia. The disease is caused by cold reactive autoantibodies that induce hemolysis through the activation of the complement pathway. Most patients with CAD are elderly, a
Externí odkaz:
https://doaj.org/article/6099d3dba626417ca31cd1d19cda037f
Publikováno v:
Clinical Case Reports, Vol 11, Iss 11, Pp n/a-n/a (2023)
Key Clinical Message Erythema nodosum (EN) is a type of panniculitis occurring due to various conditions. It can be associated with certain malignancies or manifest as a side effect of drugs. This article presents a unique case of EN in a patient wit
Externí odkaz:
https://doaj.org/article/fbd8528b0f6848fdb1d89f264ef024e8
Publikováno v:
eJHaem, Vol 2, Iss 3, Pp 545-550 (2021)
Abstract Tyrosine kinase inhibitors (TKIs) are the key agents for treating CML and BCR–ABL+ B‐ALL. Dasatinib is a potent second‐generation TKI. Here, we have discussed the case of a 51‐year‐old gentleman diagnosed with B‐myeloid mixed‐p
Externí odkaz:
https://doaj.org/article/5198a8586307400a835a742016deebde
Autor:
Yousra El Alaoui, Adel Elomri, Marwa Qaraqe, Regina Padmanabhan, Ruba Yasin Taha, Halima El Omri, Abdelfatteh EL Omri, Omar Aboumarzouk
Publikováno v:
Journal of Medical Internet Research, Vol 24, Iss 7, p e36490 (2022)
BackgroundMachine learning (ML) and deep learning (DL) methods have recently garnered a great deal of attention in the field of cancer research by making a noticeable contribution to the growth of predictive medicine and modern oncological practices.
Externí odkaz:
https://doaj.org/article/679ba879c0284890998cbae8fb39a8b2
Autor:
Shehab F. Mohamed, Feryal Helmi, Susanna El-Akiki, Halima El Omri, Abdulqadir Nashwan, Mohamed A. Yassin
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 3, Pp 922-927 (2019)
Hairy cell leukemia (HCL) is rare type of leukemia. This neoplasm is well-known to present with pancytopenia and splenomegaly. HCL is associated with BRAF mutation in 100% of cases. It is also associated with hematological and oncological malignancie
Externí odkaz:
https://doaj.org/article/af38cfd93d734ae59bc029917a93a060
Autor:
Halima El Omri, Ruba Yasin Taha, Adel Elomri, Nancy Kacem, Hesham Elsabah, Anil Yousaf Ellahie, Amna Gamil, Firyal Ibrahim, Dina Sameh Abdelrahman Soliman, Susanna Jane Lawson El Akiki, Zafar Nawaz, Ahmad Al Sabbagh, Abdelfatteh El Omri
Publikováno v:
Frontiers in Genetics, Vol 11 (2020)
The current study retrospectively evaluated cytogenetic profiles, various prognostic factors, and survival outcomes in 128 acute myeloid leukemia (AML) patients (14 ≤ age ≤ 70 years) admitted to the National Center for Cancer Care and Research (N
Externí odkaz:
https://doaj.org/article/784d855a8e154c93b215db772c9752d5